Sti Pharma Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Sti Pharma

Access the complete profile.

Sti Pharma Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	325412 Pharmaceutical Preparation Manufacturing
Address	32 Blacksmith Rd Newtown, PA 18940

Note: Revenues for privately held companies are statistical evaluations.


Sti Pharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Sti Pharma's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Sti Pharma is classified as operating in the Pharmaceutical Preparation Manufacturing industry, NAICS Code 325412.

Sti Pharma Annual Revenue and Growth Rate

Sti Pharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Sti Pharma's revenues are gauged from an analysis of company filings.

Sti Pharma's Income Statement (based on Industry Averages)

Sti Pharma P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Sti Pharma is developing and marketing. Sti Pharma doesn't have any recent trademark applications, indicating Sti Pharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
TRIACIN-C Pharmaceutical Preparation, namely, antitussive, decongestant cold preparation containing codeine	02/22/2013
SULFATRIM Oral antibacterial preparation made in significant part of sulfamethoxazole and trimethoprim	10/01/2012

See all trademarks and details in the Full Report.

Market Share of Sti Pharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Sti Pharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
MERIDIAN MEDICAL TECHNOLOGIES	Columbia, MD	100
SYNTRON BIORESEARCH	Carlsbad, CA	55
RLS USA	Lake Zurich, IL	49
ALORA PHARMACEUTICALS	Alpharetta, GA	42
LANTHEUS HOLDINGS	North Billerica, MA	33
BROADVIEW INVESTMENTS	Royston, GA	32
RESULTS RNA	Orem, UT	29
CIVICA	Lehi, UT	28
HARMONY BIOSCIENCES	Plymouth Meeting, PA	24

Nearby Competitors

These companies are similar in business line and location to Sti Pharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PEL HEALTHCARE	Sellersville, PA	100
LAMPIRE BIOLOGICAL LABS	Pipersville, PA	56
POWDERSIZE LLC DBA MICROSIZE	Quakertown, PA	35
I 3 PHARMACEUTICALS	Warminster, PA	23
PENN LIFE SCIENCES	Newtown, PA	13
EMERGEX USA	Doylestown, PA	12

Future Competition: Sti Pharma's Fastest Growing Competitors

These companies are in the same general field as Sti Pharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)